Koninklijke Philips Goodwill and Intangible Assets 2010-2023 | PHG
Koninklijke Philips goodwill and intangible assets from 2010 to 2023. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- Koninklijke Philips goodwill and intangible assets for the quarter ending September 30, 2023 were $14.571B, a 11.4% increase year-over-year.
- Koninklijke Philips goodwill and intangible assets for 2023 were $14.141B, a 2.49% decline from 2022.
- Koninklijke Philips goodwill and intangible assets for 2022 were $14.502B, a 14.21% decline from 2021.
- Koninklijke Philips goodwill and intangible assets for 2021 were $16.903B, a 34.39% increase from 2020.
| Koninklijke Philips Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023 | $14,141 |
| 2022 | $14,502 |
| 2021 | $16,903 |
| 2020 | $12,578 |
| 2019 | $13,574 |
| 2018 | $14,281 |
| 2017 | $12,493 |
| 2016 | $13,777 |
| 2015 | $13,565 |
| 2014 | $13,992 |
| 2013 | $12,972 |
| 2012 | $13,734 |
| 2011 | $15,338 |
| 2010 | $16,245 |
| 2009 | $16,070 |
| Koninklijke Philips Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2023-06-30 | $14,571 |
| 2023-03-31 | |
| 2022-06-30 | $16,534 |
| 2021-06-30 | $16,651 |
| 2020-06-30 | $13,080 |
| 2019-06-30 | $13,657 |
| 2018-06-30 | $13,640 |
| 2017-06-30 | $10,111 |
| 2016-12-31 | $13,777 |
| 2016-09-30 | $13,305 |
| 2016-06-30 | $13,541 |
| 2016-03-31 | $13,008 |
| 2015-12-31 | $13,565 |
| 2015-09-30 | $13,270 |
| 2015-06-30 | $13,587 |
| 2015-03-31 | $14,200 |
| 2014-12-31 | $13,992 |
| 2014-09-30 | $13,846 |
| 2014-06-30 | $13,356 |
| 2014-03-31 | $13,257 |
| 2013-12-31 | $12,972 |
| 2013-09-30 | $13,319 |
| 2013-06-30 | $13,640 |
| 2013-03-31 | $14,168 |
| 2012-12-31 | $13,734 |
| 2012-09-30 | $13,789 |
| 2012-06-30 | $14,587 |
| 2012-03-31 | $14,156 |
| 2011-12-31 | $15,338 |
| 2011-09-30 | $14,866 |
| 2011-06-30 | $14,354 |
| 2011-03-31 | $15,789 |
| 2010-12-31 | $16,245 |
| 2010-09-30 | $15,437 |
| 2010-06-30 | $16,846 |
| 2010-03-31 | $16,841 |
| 2009-12-31 | $16,070 |
| 2009-09-30 | $16,303 |
| 2009-06-30 | $16,081 |
| 2009-03-31 | $15,823 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $19.567B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
| Stryker (SYK) | United States | $127.690B | 31.66 |
| Boston Scientific (BSX) | United States | $107.347B | 34.19 |
| Medtronic (MDT) | Ireland | $105.881B | 14.99 |
| EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
| ResMed (RMD) | United States | $32.074B | 30.08 |
| Terumo (TRUMY) | Japan | $24.746B | 34.95 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
| Baxter (BAX) | United States | $20.379B | 14.86 |
| Insulet (PODD) | United States | $11.637B | 61.10 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
| BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
| Haemonetics (HAE) | United States | $4.621B | 23.63 |
| Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
| Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
| GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
| Envista Holdings (NVST) | United States | $3.504B | 13.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
| QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
| ICU Medical (ICUI) | United States | $2.311B | 17.24 |
| TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
| Owens & Minor (OMI) | United States | $1.922B | 18.45 |
| Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
| AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
| Warby Parker (WRBY) | United States | $1.271B | 0.00 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $0.911B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
| Evolus (EOLS) | United States | $0.662B | 0.00 |
| Jin Medical (ZJYL) | China | $0.626B | 0.00 |
| Quanterix (QTRX) | United States | $0.595B | 0.00 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
| PetIQ (PETQ) | United States | $0.486B | 18.16 |
| TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
| ZimVie (ZIMV) | United States | $0.431B | 26.37 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
| Zynex (ZYXI) | United States | $0.361B | 41.52 |
| Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
| FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| InterCure (INCR) | Israel | $0.121B | 20.46 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.77 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |